Glifest- T
(Ceftazidime 1g+ Tobramycin Injection)
Overview:
GLIFEST T Injection contains Ceftazidime and Tobramycin. Ceftazidime is one of the few in Cephalosporin class with activity against Pseudomonas. Tobramycin is an aminoglycoside antibiotic.
GLIFEST T Injection contains Ceftazidime and Tobramycin. Ceftazidime is one of the few in Cephalosporin class with activity against Pseudomonas. Tobramycin is an aminoglycoside antibiotic.

Ceftazidime, a third generation Cephalosporin antibiotic. Tobramycin is an aminoglycoside antibiotic.
Antibacterial.
GLIFEST Injection can be used in the treatment of the following conditions:
- Lower respiratory tract infections
- Skin and skin structure infections
- Urinary tract infections
- Bacterial septicemia
- Bone and joint infections
- Gynecologic infections
- Intra abdominal infections (including peritonitis)
- Central nervous system infections (including meningitis).
1-2 GLIFEST Injections by IV or IM, every 8-12 hours, or as directed by Physician
Ceftazidime inhibits cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
Related Products